N.32N.32 (Jul 2026)
Artificial Intelligence in Clinical Neuroscience: Predictive Biomarkers in Neurodegenerative Diseases
DOI 10.6084/m9.figshare.33457168
Journal archive
Issues & Archive
Explore every edition of Frontiers of BioScience, organized as a visual scientific archive.
Current volume
2026
13 issues
N.31N.31 (Jul 2026)
Circadian Disruption and Metabolic Endotoxemia: The Temporal Dimension of Dysbiosis-Induced Pathophysiology
DOI 10.6084/m9.figshare.33457159
N.30N.30 (Jun 2026)
Microbiota-Derived Metabolites and Neuropsychiatric Disorders: Butyrate, Propionate, and Secondary Bile Acids as Neuromodulators
DOI 10.6084/m9.figshare.33457144
N.29N.29 (Jun 2026)
Inflammatory Subphenotypes of Depression: From Metabolic Endotoxemia to Precision Psychiatry
DOI 10.6084/m9.figshare.33457123
N.28N.28 (May 2026)
Regulatory Science for Engineered Live Biotherapeutics: From Chemistry, Manufacturing and Controls to Clinical Trial Design
DOI 10.6084/m9.figshare.33457102
N.27N.27 (May 2026)
Plant-Derived Extracellular Vesicles: A New Frontier for Oral and Brain Delivery of Bioactive Compounds
DOI 10.6084/m9.figshare.33457129
N.26N.26 (Apr 2026)
Antimicrobial Resistance and the Microbiome: Probiotics, Postbiotics and Phage-Based alternatives in the post-antibiotic era
DOI 10.6084/m9.figshare.33457096
N.25N.25 (Apr 2026)
The Gut Microbiota, Circadian Rhythms and Sleep: Microbial Metabolites as Modulators of the Sleep-Wake Cycle
DOI 10.6084/m9.figshare.33457036
N.24N.24 (Mar 2026)
Post-exotic fermented foods: Innovations in plant matrices and alternative proteins.
DOI 10.6084/m9.figshare.31839403
N.23N.23 (Feb 2026)
Nanosensors for probiotic monitoring: reality or science fiction?
DOI 10.6084/m9.figshare.31836775
N.22N.22 (Feb 2026)
Fourth Generation Probiotics: metabolic engineering and applications in neurodegenerative diseases
DOI 10.6084/m9.figshare.31835953
N.21N.21 (Jan 2026)
Designing the Gut Brain Interface: Delivery Engineering and the Future of Pediatric Microbiome Interventions
DOI 10.6084/m9.figshare.31431073
N.20N.20 (Jan 2026)
Estrobolome, gut microbiota and estrogen dependent diseases: endocrine immunemetabolic integration and new translational frontiers
DOI 10.6084/m9.figshare.31501723
Archive
2025
19 issues
N.19N.19 (Dec 2025)
MAMPs: the invisible language between microorganisms and the immune system
DOI 10.6084/m9.figshare.31453786
N.18N.18 (Dec 2025)
Neuroendocrine and Microbiome Dimensions of GLP 1 Receptor Agonism in Obesity Management
DOI 10.6084/m9.figshare.31444741
N.17N.17 (Nov 2025)
Metabolomics for early diagnosis, pathophysiological understanding, and monitoring of neurological diseases: Organic acids and biochemical biomarkers
DOI 10.6084/m9.figshare.30898994
N.16N.16 (Nov 2025)
Engineered Microbiota and Bacterial Extracellular Vesicles: Programming the Gut Brain Axis for Precision Therapies
DOI 10.6084/m9.figshare.30898160
N.15N.15 (Oct 2025)
Nanotechnology for Oral Bioavailability of Drugs and Nutraceuticals: Applications in Neuroscience and Well‑Being
DOI 10.6084/m9.figshare.30500912
N.14N.14 (Sep 2025)
Plant bioactives and nanotechnology: The new frontier for personalized dermatological treatment
DOI 10.6084/m9.figshare.30234703
N.13N.13 (Sep 2025)
The Role of Postbiotics and Metabolomics in Modulating the Gut-Brain Axis
DOI 10.6084/m9.figshare.30081094
N.12N.12 (Aug 2025)
Psychobiotics and Epigenetics: Reprogramming emotional pathways
DOI 10.6084/m9.figshare.29924963
N.11N.11 (Aug 2025)
Probiotics and Fullerenes: A Converging Frontier for Neuroprotection and Gut–Brain Axis Modulation
DOI 10.6084/m9.figshare.29885819
N.10N.10 (Aug 2025)
Gestational Diabetes and the Maternal Microbiome: The Role of Probiotics in Metabolic and Immune Modulation
DOI 10.6084/m9.figshare.29815184
N.9N.9 (Jul 2025)
Microbiome-based neurocosmetics: Innovation and application paths
DOI 10.6084/m9.figshare.29651651
N.8N.8 (Jul 2025)
Biotechnology and artificial intelligence in aesthetics: A new approach to melasma diagnosis
DOI 10.6084/m9.figshare.29602637
N.7N.7 (Jul 2025)
USE OF PROBIOTICS DURING PREGNANCY AND IMPLICATIONS FOR MATERNAL AND NEONATAL HEALTH: A CRITICAL REVIEW
DOI 10.6084/m9.figshare.29549003
N.6N.6 (Jul 2025)
The future of plant tissue culture biotechnology in dermocosmetics: Innovations in sustainable skincare
DOI 10.6084/m9.figshare.29509727
N.5N.5 (Jun 2025)
Exhaled Metabolomics: a new frontier in real-time microbiome-based diagnostics and precision medicine
DOI 10.6084/m9.figshare.29509694
N.4N.4 (Jun 2025)
Reprogramming emotions: psychobiotics and epigenetics in anxiety and depression therapy
DOI 10.6084/m9.figshare.29509685
N.3N.3 (Jun 2025)
Redesigning Psychiatry - The new era of biotechnology, the microbiome, and translational neuroscience
DOI 10.6084/m9.figshare.29509679
N.2N.2 (Jun 2025)
Microbiota, Immunity and Neuroplasticity - The Forgotten Triad of Modern Mental Health
DOI 10.6084/m9.figshare.29509646
N.1N.1 (May 2025)
From Collapse to Control - How Precision Biotechnology and Probiotics Could Redefine the Post-Antibiotic Era
DOI 10.6084/m9.figshare.29378249